![Dan Dan Dong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dan Dan Dong
Direttore/Membro del Consiglio presso INNOCARE PHARMA LIMITED
Posizioni attive di Dan Dan Dong
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | 01/08/2021 | - |
INNOCARE PHARMA LIMITED | Direttore/Membro del Consiglio | 11/10/2023 | - |
Independent Dir/Board Member | 11/10/2023 | - | |
VISEN Pharmaceuticals
![]() VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | 07/11/2018 | - |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
![]() VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Direttore/Membro del Consiglio | 01/02/2019 | - |
Storia della carriera di Dan Dan Dong
Precedenti posizioni note di Dan Dan Dong
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vivo Capital LLC
![]() Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Corporate Officer/Principal | 01/08/2011 | 01/07/2021 |
Shanghai Rarestone Health Tech Group Co. Ltd.
![]() Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Fondatore | - | - |
Formazione di Dan Dan Dong
Sichuan University | Undergraduate Degree |
Fudan University | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 7 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ARRIVENT BIOPHARMA, INC. | Health Technology |
INNOCARE PHARMA LIMITED | Health Technology |
Aziende private | 4 |
---|---|
VISEN Pharmaceuticals
![]() VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Health Technology |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
![]() VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Health Technology |
Vivo Capital LLC
![]() Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
![]() Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
- Borsa valori
- Insiders
- Dan Dan Dong
- Esperienza